Trevi Therapeutics TRVI
NASDAQ TRVI
$13.93 -0.25 (-1.76%)
As of: Oct 2, 2026 · 3:58 PM EDT

Trevi Therapeutics (TRVI) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Trevi Therapeutics' Depreciation & Amortization (CF) came in at $34,000 for Q2 2026, down 10.5% from $38,000 a year earlier and unchanged from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Trevi Therapeutics reported Depreciation & Amortization (CF) of $137,000, down 8.1% year-over-year; for FY2025, it was $144,000, down 2.0% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 25.1% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $147,000 in FY2024 (+19.5%), $123,000 in FY2023 (+186.0%), $43,000 in FY2022 (-14.0%) and $50,000 in FY2021 (+6.4%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $8,000 (Q2 2022) to $38,000 (Q3 2025).
  • Year-over-year, Depreciation & Amortization (CF) has declined for three consecutive quarters, with an average decline of 1.8% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2023 (growth of 325.0%), and the weakest in Q2 2022 (a decline of 33.3%).
  • Business Quant data shows TRVI's Depreciation & Amortization (CF) at $34,000 (Q1 2026), $31,000 (Q4 2025) and $38,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Trevi Therapeutics 2.04 Bn 2.04 Bn - 34,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34,000.00
Mar 31, 2026 34,000.00
Dec 31, 2025 31,000.00
Sep 30, 2025 38,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 37,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 36,000.00
Jun 30, 2024 38,000.00
Mar 31, 2024 35,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 35,000.00
Jun 30, 2023 34,000.00
Mar 31, 2023 19,000.00
Dec 31, 2022 15,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 8,000.00
Mar 31, 2022 11,000.00
Dec 31, 2021 12,000.00
Sep 30, 2021 13,000.00
API Access

Trevi Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TRVI&period=max&api_key=YOUR_API_KEY